A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment
Clinical trial NCT03780972 · COMPLETED
Trial details
- NCT number
- NCT03780972
- Sponsor
- ONL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2021-08-24
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.